Nchi: Kanada
Lugha: Kiingereza
Chanzo: Health Canada
ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE
MARCAN PHARMACEUTICALS INC
N02AJ13
TRAMADOL AND PARACETAMOL
325MG; 37.5MG
TABLET
ACETAMINOPHEN 325MG; TRAMADOL HYDROCHLORIDE 37.5MG
ORAL
30/500
Narcotic (CDSA I)
OPIATE AGONISTS
Active ingredient group (AIG) number: 0250601001; AHFS:
APPROVED
2012-09-04
1 | P a g e PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION N MAR-TRAMADOL/ACET Acetaminophen and Tramadol hydrochloride tablets, House Std 37.5 mg tramadol hydrochloride/325 mg acetaminophen Opioid Analgesic and Centrally Acting Analgesic Marcan Pharmaceuticals Inc. 2 Gurdwara Road, Suite #112, Ottawa, ON, K2E 1A2 Date of Revision: JAN 24, 2023 Control # 271044 2 | P a g e TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ......................................................... 3 SUMMARY PRODUCT INFORMATION ............................................................................... 3 INDICATIONS AND CLINICAL USE ..................................................................................... 3 CONTRAINDICATIONS ........................................................................................................... 4 WARNINGS AND PRECAUTIONS ......................................................................................... 4 ADVERSE REACTIONS ......................................................................................................... 17 DRUG INTERACTIONS ......................................................................................................... 22 DOSAGE AND ADMINISTRATION ................................................................................... 288 OVERDOSAGE ...................................................................................................................... 311 ACTION AND CLINICAL PHARMACOLOGY .................................................................. 332 STORAGE AND STABILITY ................................................................................................. 39 SPECIAL HANDLING INSTRUCTIONS ............................................................................... 40 DOSAGE FORMS, COMPOSITION AND PACKAGING .................................................... 40 PART II: SCIENTIFIC INFORMATION ............................................................................. 411 PHARMACEUTICAL INF Soma hati kamili